113 related articles for article (PubMed ID: 35312859)
1. Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : An initiative of the Central European Cooperative Oncology Group (CECOG).
Thallinger C; Berzinec P; Bicakcic E; Dan A; Fabian G; Gales LN; Kuhar CG; Janzic U; Kahan Z; Mencinger M; Penthedourakis G; Sgouros J; Simetic L; Sirbu D; Vosmik M; Wrona A; Zielinski C
Wien Klin Wochenschr; 2022 Oct; 134(19-20):697-704. PubMed ID: 35312859
[TBL] [Abstract][Full Text] [Related]
2. The Emergence of Virtual Tumor Boards in Neuro-Oncology: Opportunities and Challenges.
Ekhator C; Kesari S; Tadipatri R; Fonkem E; Grewal J
Cureus; 2022 Jun; 14(6):e25682. PubMed ID: 35677741
[TBL] [Abstract][Full Text] [Related]
3. "What's measured gets done": a call for a European semester for cancer to improve cancer outcomes in Central and Southeastern Europe.
Zielinski C; Thallinger C; Rödiger A
Arch Public Health; 2023 Aug; 81(1):142. PubMed ID: 37553609
[TBL] [Abstract][Full Text] [Related]
4. Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Nappi L; Ottaviano M; Rescigno P; Tortora M; Banna GL; Baciarello G; Basso U; Canil C; Cavo A; Cossu Rocca M; Czaykowski P; De Giorgi U; Garcia Del Muro X; Di Napoli M; Fornarini G; Gietema JA; Heng DYC; Hotte SJ; Kollmannsberger C; Maruzzo M; Messina C; Morelli F; Mulder S; Nichols C; Nolè F; Oing C; Sava T; Secondino S; Simone G; Soulieres D; Vincenzi B; Zucali PA; De Placido S; Palmieri G; ; ;
Oncologist; 2020 Oct; 25(10):e1509-e1515. PubMed ID: 32735386
[TBL] [Abstract][Full Text] [Related]
5. Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement.
Vrdoljak E; Bodoky G; Jassem J; Popescu RA; Mardiak J; Pirker R; Čufer T; Bešlija S; Eniu A; Todorović V; Kubáčková K; Kurteva G; Tomašević Z; Sallaku A; Smichkoska S; Bajić Ž; Šikić BI
Oncologist; 2016 Oct; 21(10):1183-1190. PubMed ID: 27401890
[TBL] [Abstract][Full Text] [Related]
6. Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis.
Cufer T; Ciuleanu TE; Berzinec P; Galffy G; Jakopovic M; Jassem J; Jovanovic D; Mihaylova Z; Ostoros G; Thallinger C; Zemanova M; Zielinski C
Oncologist; 2020 Mar; 25(3):e598-e601. PubMed ID: 32162818
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
Mokos M; Bašić-Jukić N
Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
[TBL] [Abstract][Full Text] [Related]
8. The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group.
Skrzat-Klapaczyńska A; Kowalska JD; Afonina L; Antonyak S; Balayan T; Begovac J; Bursa D; Dragovic G; Gokengin D; Harxhi A; Jilich D; Kase K; Lakatos B; Mardarescu M; Matulionyte R; Oprea C; Panteleev A; Papadopoulos A; Sojak L; Tomazic J; Vassilenko A; Vasylyev M; Verhaz A; Yancheva N; Yurin O; Horban A
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805250
[TBL] [Abstract][Full Text] [Related]
9. Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group.
Ryska A; Buiga R; Fakirova A; Kern I; Olszewski W; Plank L; Seiwerth S; Toth E; Zivka E; Thallinger C; Zielinski C; Brcic L
Oncologist; 2018 Dec; 23(12):e152-e158. PubMed ID: 30076278
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and oncological disease.
Šálek T; Slopovský J; Pörsök Š; Pazderová N; Mináriková Z; Zomborská E; Špánik B
Klin Onkol; 2021; 34(3):211-219. PubMed ID: 34362259
[TBL] [Abstract][Full Text] [Related]
11. National Cancer Grid Virtual Tumor Boards of Head and Neck Cancers: An Innovative Approach to Multidisciplinary Care.
Thiagarajan S; Poojari V; Tuljapurkar V; Ghosh-Laskar S; Fatehi K; Babu S; Penumadu P; Patil A; Joshi A; Kumar S; Chaukar D; Kannan R; Pramesh CS
JCO Glob Oncol; 2023 Jan; 9():e2200348. PubMed ID: 36706349
[TBL] [Abstract][Full Text] [Related]
12. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
13. Assessing the feasibility of a virtual tumor board program: a case study.
Shea CM; Teal R; Haynes-Maslow L; McIntyre M; Weiner BJ; Wheeler SB; Jacobs SR; Mayer DK; Young M; Shea TC
J Healthc Manag; 2014; 59(3):177-93. PubMed ID: 24988672
[TBL] [Abstract][Full Text] [Related]
14. Follow-up evaluation of a web-based pediatric brain tumor board in Latin America.
Rosabal-Obando M; Osorio DS; Lassaletta A; La Madrid AM; Bartels U; Finlay JL; Qaddoumi I; Rutkowski S; Mynarek M
Pediatr Blood Cancer; 2021 Sep; 68(9):e29073. PubMed ID: 34003601
[TBL] [Abstract][Full Text] [Related]
15. Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey.
Schäfer N; Bumes E; Eberle F; Fox V; Gessler F; Giordano FA; Konczalla J; Onken J; Ottenhausen M; Scherer M; Schneider M; Vatter H; Herrlinger U; Schuss P
J Neurooncol; 2021 Jul; 153(3):479-485. PubMed ID: 34115248
[TBL] [Abstract][Full Text] [Related]
16. HIV care in times of the COVID-19 crisis - Where are we now in Central and Eastern Europe?
Kowalska JD; Skrzat-Klapaczyńska A; Bursa D; Balayan T; Begovac J; Chkhartishvili N; Gokengin D; Harxhi A; Jilich D; Jevtovic D; Kase K; Lakatos B; Matulionyte R; Mulabdic V; Nagit A; Papadopoulos A; Stefanovic M; Vassilenko A; Vasylyev M; Yancheva N; Yurin O; Horban A;
Int J Infect Dis; 2020 Jul; 96():311-314. PubMed ID: 32413608
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges.
Moubarak S; Merheb D; Basbous L; Chamseddine N; Bou Zerdan M; Assi HI
J Int Med Res; 2022 Sep; 50(9):3000605221125047. PubMed ID: 36154328
[TBL] [Abstract][Full Text] [Related]
18. Virtual Tumor Board Increases Provider Attendance and Case Presentations.
Davis CH; Ho J; Stephenson R; August DA; Gee H; Weiner J; Alexander HR; Pitt HA; Berger AC
JCO Oncol Pract; 2022 Oct; 18(10):e1603-e1610. PubMed ID: 35939774
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a Regional Virtual Tumor Board Program to Improve the Process of Care for Patients With Hepatocellular Carcinoma.
Salami AC; Barden GM; Castillo DL; Hanna M; Petersen NJ; Davila JA; Naik AD; Anaya DA
J Oncol Pract; 2015 Jan; 11(1):e66-74. PubMed ID: 25466708
[TBL] [Abstract][Full Text] [Related]
20. Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe.
Vrdoljak E; Bodoky G; Jassem J; Popescu R; Pirker R; Čufer T; Bešlija S; Eniu A; Todorović V; Kopečková K; Kurteva G; Tomašević Z; Sallaku A; Smichkoska S; Bajić Ž; Sikic B
Oncologist; 2019 Jan; 24(1):e30-e37. PubMed ID: 30181313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
